For example, our results suggest that miRNA-181c and the methylation level of DIRAS3 both contribute to the alteration of DIRAS3 expression (module 1 in Figure 4), which may, in turn, affect the GBM survival time. The gene discussed is DIRAS3; the disease is glioblastoma.